Strata Critical Medical (NASDAQ:SRTA) Rating Increased to Strong-Buy at B. Riley Financial

Strata Critical Medical (NASDAQ:SRTA) was upgraded by stock analysts at B. Riley Financial to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.

A number of other equities analysts have also commented on the stock. Weiss Ratings assumed coverage on shares of Strata Critical Medical in a research report on Tuesday. They set a “hold (c-)” rating on the stock. Craig Hallum started coverage on shares of Strata Critical Medical in a report on Wednesday. They issued a “buy” rating and a $8.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $8.00.

Strata Critical Medical Stock Up 1.9%

SRTA opened at $4.38 on Tuesday. Strata Critical Medical has a fifty-two week low of $2.35 and a fifty-two week high of $6.02.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.